CLINICAL_TRIALS
trial_result
· 2024-10-08
Clinical Trial Update: Xeljanz Special Investigation for Long-term Use in UC Patients
Summary
Pfizer's Xeljanz (tofacitinib) long-term-use study in ulcerative colitis has completed and results were posted on 2024-10-08.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Ulcerative Colitis | Status: COMPLETED | Results posted: 2024-10-08